Publicaciones en colaboración con investigadores/as de Hospital Universitario Central de Asturias (19)

2021

  1. Cancer stem cells as a source of drug resistance in bone sarcomas

    Journal of Clinical Medicine, Vol. 10, Núm. 12

2020

  1. GARP promotes the proliferation and therapeutic resistance of bone sarcoma cancer cells through the activation of TGF-β

    Cell Death and Disease, Vol. 11, Núm. 11

  2. Impaired condensin complex and Aurora B kinase underlie mitotic and chromosomal defects in hyperdiploid B-cell ALL

    Blood, Vol. 136, Núm. 3, pp. 313-327

  3. Sox2 expression and transcriptional activity identifies a subpopulation of cancer stem cells in sarcoma with prognostic implications

    Cancers, Vol. 12, Núm. 4

2019

  1. New chondrosarcoma cell lines with preserved stem cell properties to study the genomic drift during in vitro/in vivo growth

    Journal of Clinical Medicine, Vol. 8, Núm. 4

  2. The multikinase inhibitor EC-70124 synergistically increased the antitumor activity of doxorubicin in sarcomas

    International Journal of Cancer, Vol. 145, Núm. 1, pp. 254-266

  3. The novel role of SOX2 as an early predictor of cancer risk in patients with laryngeal precancerous lesions

    Cancers, Vol. 11, Núm. 3

2018

  1. Distinctive expression and amplification of genes at 11q13 in relation to HPV status with impact on survival in head and neck cancer patients

    Journal of Clinical Medicine, Vol. 7, Núm. 12

  2. FUS-CHOP Promotes Invasion in Myxoid Liposarcoma through a SRC/FAK/RHO/ROCK-Dependent Pathway

    Neoplasia (United States), Vol. 20, Núm. 1, pp. 44-56

  3. Immunohistochemical expression of cortactin and focal adhesion kinase predicts recurrence risk and laryngeal cancer risk beyond histologic grading

    Cancer Epidemiology Biomarkers and Prevention, Vol. 27, Núm. 7, pp. 805-813

2017

  1. A Novel Role for Nanog As An Early Cancer Risk Marker in Patients with Laryngeal Precancerous Lesions

    Scientific Reports, Vol. 7, Núm. 1

  2. Annexin A1 down-regulation in head and neck squamous cell carcinoma is mediated via transcriptional control with direct involvement of miR-196a/b

    Scientific Reports, Vol. 7, Núm. 1

  3. Dysregulation of miR-196b in head and neck cancers leads to pleiotropic effects in the tumor cells and surrounding stromal fibroblasts

    Scientific Reports, Vol. 7, Núm. 1

2015

  1. Clinical significance of Anoctamin-1 gene at 11q13 in the development and progression of head and neck squamous cell carcinomas

    Scientific Reports, Vol. 5

2012

  1. Frequent aberrant expression of the human ether à go-go (hEAG1) potassium channel in head and neck cancer: Pathobiological mechanisms and clinical implications

    Journal of Molecular Medicine, Vol. 90, Núm. 10, pp. 1173-1184

2011

  1. Cortactin and focal adhesion kinase as predictors of cancer risk in patients with laryngeal premalignancy

    Cancer Prevention Research, Vol. 4, Núm. 8, pp. 1333-1341

  2. Regulation of the expression of death receptors and their ligands by melatonin in haematological cancer cell lines and in leukaemia cells from patients

    Journal of Pineal Research, Vol. 50, Núm. 3, pp. 345-355

2010

  1. Expression and clinical significance of the Kv3.4 potassium channel subunit in the development and progression of head and neck squamous cell carcinomas

    Journal of Pathology, Vol. 221, Núm. 4, pp. 402-410

2009

  1. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas

    Journal of Pathology, Vol. 217, Núm. 4, pp. 516-523